Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
about
Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity.Inhibition of microglia activation as a phenotypic assay in early drug discoveryA Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure.Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigensInflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosisEstrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.Bringing CLARITY to gray matter atrophy.Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.Reduction in parvalbumin-positive interneurons and inhibitory input in the cortex of mice with experimental autoimmune encephalomyelitisInflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosisEstriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.Microglia in the normally aged hippocampus.Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imagingOral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.Automated measurement of nerve fiber density using line intensity scan analysis.Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis miceAstrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis.Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide.Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune EncephalomyelitisTherapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating diseaseAbnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisCognitive impairment in multiple sclerosis: a forgotten disability remembered.Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelinationSaturable leptin transport across the BBB persists in EAE miceDetection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis.Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis.Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.An animal model of cortical and callosal pathology in multiple sclerosis.Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activationMicroglial activation and chronic neurodegeneration.Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.
P2860
Q22001061-89B9E947-9569-496E-96C9-7E1255C7A9DAQ26996061-C0025C86-F25B-4296-B54C-40104AE66ADFQ27308753-DD87A518-E2C8-4474-806C-5F526E0EF96BQ27334415-E4994DE8-9EA0-48E9-9E29-35E8694658BDQ28483194-B5676D50-54C9-457E-8D13-6799F81C728BQ30433883-602407E5-E6CC-4F17-8E1D-C7EAD73E6A70Q30479247-FE4146CC-B17B-4637-9E2C-CE2B27AFCABBQ30530185-35DF1022-608C-469B-ADE5-19BA5EDF453BQ30651109-12BB2EE2-B807-4943-A7D2-A0DA120BB812Q30805627-C075BFC3-383A-4264-90A9-56AC6B4C0AE1Q33749413-99695A07-8D7C-4EAF-AE36-D064035560E9Q34565099-296303D4-7299-435C-9FC1-4917ECCF31DAQ34570124-C4409286-9306-4C7E-BF79-6F2EBC4C7DEBQ35065539-D7CB2036-FBE9-4AD1-A0DC-9F01C6631026Q35078252-E1A893D6-60CF-4B5B-91E5-5B5CD488642EQ35128484-6A12BCB1-80B1-483F-A28A-32481BD934C3Q35129497-7481FCCC-75D9-4563-860C-7457CC0132A0Q35285454-BC100782-F2CF-4B8C-8D4A-70F4F837A76BQ35800453-5E3F96F7-8E68-4C72-AA85-6E809CE28E07Q35853209-2C49C9AC-2203-4C86-853A-1FA64B9C89E3Q35982115-351A789E-37CC-4D1E-BC2A-7663B9DE501AQ36088247-B986ED25-ECDA-47E6-9D19-E3521F75080FQ36098974-04D5C015-29FB-4EB1-B8A4-9AFE12E39EFAQ36138217-D8148E84-DF9E-4796-805C-2B9DD1E5511FQ36209917-6072B9F9-6215-4AAF-97AF-B741A04A08C1Q36507780-74A5E9D2-08F1-4995-948F-80801C3A489EQ36608070-F052DE46-8671-4CAA-A47E-BD4867148DA7Q36610373-92741C0E-6D09-40AF-A4F8-13789C972155Q36616476-4E50400F-7084-4493-A50C-14968005D06EQ36773824-20011FE3-BBC0-45FA-A841-BE1F49989187Q37053848-E29A3721-C57F-4C8B-B4FD-AECD1020FCD9Q37107165-D3615347-56DC-4907-843B-155898C8B54AQ37144845-7CFAE1FD-351B-4F20-B499-EAFD852DD7B9Q37350716-2DE86E07-DB8A-4028-8B9D-03852D6D95DFQ37380831-225FFFDE-F59F-4DCC-9811-561694123837Q37403700-F9CFF545-124F-4A78-9F5E-6620D05E6FE6Q37584143-0771A190-F4F1-4122-81C3-F07CC2ADB5ADQ37708436-86603DB4-D62A-409A-AC31-452D4E5F6214Q37794379-5FBFC928-4FF2-48CB-81E5-CD59F9FEEC41Q38461098-960E8A46-F087-44DC-AD15-32EE27F4538C
P2860
Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@ast
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@en
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@nl
type
label
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@ast
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@en
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@nl
prefLabel
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@ast
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@en
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@nl
P2093
P2860
P356
P1476
Hippocampal CA1 atrophy and sy ...... immune encephalomyelitis, EAE.
@en
P2093
Andrea A Avedisian
Marina O Ziehn
Rhonda R Voskuhl
Seema Tiwari-Woodruff
P2860
P2888
P304
P356
10.1038/LABINVEST.2010.6
P577
2010-02-15T00:00:00Z
P5875
P6179
1015684602